+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Immunotherapy"

From
From
Cancer Gene Therapy Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Cancer Gene Therapy Market Forecasts from 2023 to 2028

  • Report
  • October 2023
  • 152 Pages
  • Global
From
mRNA Cancer Therapies Patent Landscape 2022 - Product Thumbnail Image

mRNA Cancer Therapies Patent Landscape 2022

  • Report
  • September 2022
  • Global
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Immunotherapy in Oncology Startup Identification - Product Thumbnail Image

Immunotherapy in Oncology Startup Identification

  • Report
  • June 2020
  • 280 Pages
  • Global
Loading Indicator

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer. Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes. Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more